DDS(DDS)
DDS
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2027E | FY2028E | FY2029E |
|---|---|---|---|
| Revenue Avg | $6.62B | $6.69B | $6.85B |
| Low | $6.57B | $6.56B | $6.80B |
| High | $6.67B | $6.84B | $6.91B |
| EBITDA Avg | $1.11B | $1.12B | $1.15B |
| Low | $1.10B | $1.10B | $1.14B |
| High | $1.12B | $1.14B | $1.16B |
| EBIT Avg | $924M | $933M | $956M |
| Low | $917M | $915M | $948M |
| High | $931M | $955M | $964M |
| Net Income Avg | $601M | $533M | $562M |
| Low | $565M | $530M | $561M |
| High | $637M | $547M | $573M |
| EPS Avg | $37.77 | $34.52 | $36.35 |
| Low | $36.25 | $33.99 | $35.94 |
| High | $40.82 | $35.06 | $36.72 |
| Analysts (Rev / EPS) | 3 / 2 | 3 / 1 | 1 / 1 |
| Metric | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 |
|---|---|---|---|---|---|---|
| Revenue Avg | $1.49B | $2.02B | $1.60B | $1.55B | $1.53B | $2.04B |
| Low | $1.47B | $2.00B | $1.59B | $1.54B | $1.51B | $2.02B |
| High | $1.51B | $2.04B | $1.61B | $1.56B | $1.54B | $2.05B |
| EBITDA Avg | $250M | $338M | $268M | $260M | $255M | $341M |
| Low | $246M | $335M | $266M | $257M | $253M | $338M |
| High | $253M | $341M | $270M | $262M | $258M | $344M |
| EBIT Avg | $208M | $282M | $224M | $217M | $213M | $284M |
| Low | $205M | $280M | $222M | $215M | $211M | $282M |
| High | $211M | $284M | $225M | $218M | $215M | $287M |
| Net Income Avg | $127M | $171M | $175M | $68M | $129M | $172M |
| Low | $123M | $169M | $173M | $67M | $128M | $170M |
| High | $131M | $173M | $177M | $69M | $130M | $174M |
| EPS Avg | $8.13 | $10.96 | $11.21 | $4.36 | $8.27 | $11.01 |
| Low | $7.88 | $10.84 | $11.09 | $4.31 | $8.19 | $10.89 |
| High | $8.38 | $11.07 | $11.33 | $4.41 | $8.36 | $11.13 |
| Analysts (Rev / EPS) | 2 / 1 | 2 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |